{"owner": "ArrayExpress Uploader", "ownerprofile_id": "arrayexpress_sid", "species": "mouse", "factors": [{"GSM563584": {"SAMPLE TYPE": "tumors derived from Pax7-expressing cells in vivo", "GENOTYPE": "Pax7CE/+;LSL-KrasG12D/+;Trp53Fl/+", "ORGANISM PART": "Tumor"}}, {"GSM563584": {"SAMPLE TYPE": "tumors derived from Pax7-expressing cells in vivo", "GENOTYPE": "Pax7CE/+;LSL-KrasG12D/+;Trp53Fl/+", "ORGANISM PART": "Tumor"}}, {"GSM563584": {"SAMPLE TYPE": "tumors derived from Pax7-expressing cells in vivo", "GENOTYPE": "Pax7CE/+;LSL-KrasG12D/+;Trp53Fl/+", "ORGANISM PART": "Tumor"}}, {"GSM563587": {"SAMPLE TYPE": "tumors derived from Pax7-expressing cells in vivo", "GENOTYPE": "Pax7CE/+;LSL-KrasG12D/+;Trp53Fl/Fl", "ORGANISM PART": "Tumor"}}, {"GSM563587": {"SAMPLE TYPE": "tumors derived from Pax7-expressing cells in vivo", "GENOTYPE": "Pax7CE/+;LSL-KrasG12D/+;Trp53Fl/Fl", "ORGANISM PART": "Tumor"}}, {"GSM563587": {"SAMPLE TYPE": "tumors derived from Pax7-expressing cells in vivo", "GENOTYPE": "Pax7CE/+;LSL-KrasG12D/+;Trp53Fl/Fl", "ORGANISM PART": "Tumor"}}, {"GSM563590": {"SAMPLE TYPE": "tumors derived from CSM4B cells transformed in vitro", "GENOTYPE": "R26-Cre-ERT2;LSL-KrasG12D/+;Trp53Fl/Fl", "ORGANISM PART": "Tumor"}}, {"GSM563590": {"SAMPLE TYPE": "tumors derived from CSM4B cells transformed in vitro", "GENOTYPE": "R26-Cre-ERT2;LSL-KrasG12D/+;Trp53Fl/Fl", "ORGANISM PART": "Tumor"}}, {"GSM563590": {"SAMPLE TYPE": "tumors derived from CSM4B cells transformed in vitro", "GENOTYPE": "R26-Cre-ERT2;LSL-KrasG12D/+;Trp53Fl/Fl", "ORGANISM PART": "Tumor"}}, {"GSM563593": {"SAMPLE TYPE": "normal muscle as control for myogenic tumors", "GENOTYPE": "littermate control", "ORGANISM PART": "muscle"}}, {"GSM563593": {"SAMPLE TYPE": "normal muscle as control for myogenic tumors", "GENOTYPE": "littermate control", "ORGANISM PART": "muscle"}}, {"GSM563593": {"SAMPLE TYPE": "normal muscle as control for myogenic tumors", "GENOTYPE": "littermate control", "ORGANISM PART": "muscle"}}], "id": 8495, "pop_total": 0, "platform": 8, "summary_wrapped": "Mouse muscle stem cells, defined as Pax7+ satellite cells, can initiate rhabdomyosarcoma when transformed by oncogenic Kras and...", "geo_gse_id": "E-GEOD-22798", "owner_profile": "/profile/8773/arrayexpressuploader", "factor_count": 3, "sample_count": 12, "tags": ["muscle", "rhabdomyosarcoma", "sarcoma"], "lastmodified": "Dec.12, 2014", "is_default": false, "geo_gds_id": "", "slug": "expression-data-from-pax7-satellite-cell-derived-t", "geo_id_plat": "E-GEOD-22798_A-AFFY-36", "name": "Expression data from Pax7+ satellite cell derived tumors in vitro and in vivo", "created": "Nov.24, 2014", "summary": "Mouse muscle stem cells, defined as Pax7+ satellite cells, can initiate rhabdomyosarcoma when transformed by oncogenic Kras and concomitant loss of p53. Mouse Pax7+ satellite cells were transformed in vitro and in vivo utilizing the Cre-ER/loxp system. We wanted to address two major questions: do the in vitro and in vivo tumors cluster together compared to another mouse to another mouse derived soft-tissue sarcoma AND which human soft-tissue sarcoma do the in vivo derived tumors resemble transcriptionally?  Therefore, tumors from cells transformed in vitro and tumors from mice that restrict the oncogenic lesions to Pax7+ satellite cells in vivo were compared to answer these two questions.", "source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-22798", "sample_source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-22798/samples/"}